|
JP2010178757A
|
|
Oligonucleotide-mediated nucleic acid recombination
|
|
KR20110074871A
|
|
Method for the treatment of radiation-induced neutropenia by administration of a multi-pegylated granulocyte colony stimulating factor(g-csf) variant
|
|
EP2178560A2
|
|
Chimeric hiv antigens
|
|
AU2008202094A1
|
|
Methods and compositions for polypeptide engineering
|
|
AU2007200161A1
|
|
Novel co-stimulatory molecules
|
|
WO2007075899A2
|
|
Dual agonist compounds and uses thereof
|
|
AU2006204617A1
|
|
IFN-alpha homologues
|
|
EP1888633A2
|
|
Evolved interferon-alpha polypeptides
|
|
US2007009930A1
|
|
Methods and compositions for polypeptide engineering
|
|
US2007065838A1
|
|
Oligonucleotide mediated nucleic acid recombination
|
|
US2006257890A1
|
|
Methods and compositions for cellular and metabolic engineering
|
|
AU2005242140A1
|
|
Optimization of pest resistance genes using DNA shuffling
|
|
US2006047611A1
|
|
Methods of populating data structures for use in evolutionary simulations
|
|
AU2005202165A1
|
|
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
US2005084907A1
|
|
Methods, systems, and software for identifying functional biomolecules
|
|
US2007274950A1
|
|
Interferon-alpha polypeptides and conjugates
|
|
US2005084913A1
|
|
Novel tumor-associated antigens
|
|
US2005260605A1
|
|
Targeting of genetic vaccine vectors
|
|
AU2004200501A1
|
|
Evolution of Whole Cells and Organisms by Recursive Sequence Recombination
|
|
AU2003297285A1
|
|
Interferon-alpha polypeptides and conjugates
|
